Mystic Asset Management Inc. acquired a new position in Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 203,283 shares of the company’s stock, valued at approximately $980,000. Mystic Asset Management Inc. […]
Retirement Planning Co of New England Inc Invests $1 67 Million in Zevra Therapeutics, Inc (NASDAQ:ZVRA) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Zevra Therapeutics (NASDAQ:ZVRA – Free Report) had its target price increased by Canaccord Genuity Group from $19.00 to $20.00 in a research note published on Tuesday morning, Benzinga reports. The brokerage currently has a buy rating on the stock. Zevra Therapeutics Stock Down 4.8 % Shares of Zevra Therapeutics stock opened at $4.94 on Tuesday. […]
Zevra Therapeutics (NASDAQ:ZVRA – Get Free Report) had its target price lifted by equities research analysts at Canaccord Genuity Group from $19.00 to $20.00 in a research note issued on Tuesday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Canaccord Genuity Group’s price target points to a potential upside of 305.68% […]
Zevra Therapeutics (NASDAQ:ZVRA – Get Free Report) released its quarterly earnings results on Monday. The company reported ($0.15) EPS for the quarter, beating analysts’ consensus estimates of ($0.39) by $0.24, reports. Zevra Therapeutics had a negative return on equity of 38.83% and a negative net margin of 196.40%. The business had revenue of $8.47 million […]